Antibody
AlivaMab Discovery Services is the only organization that combines the most broadly adopted human therapeutic antibody discovery technology with the most robust discovery processes. Our end-to-end discovery workflow (including sequencing) produces fully human, functionally characterized, therapeutic antibodies in as little as 8 weeks